GoodRx (Nasdaq: GDRX), the leading platform for medication savings in the U.S., today announced a new e-commerce experience ...

GDRX rolls out a new e-commerce platform connecting users to top retail pharmacies, aiming to boost savings, improve access, and expand its digital health services.

With discounts up to 80 percent, GoodRx offers affordable solutions for consumers, whether they have insurance and even ...

GoodRx is trying to help pharmacies compete in a digital age, where they already face pressure on their margins.

Company working with Hy-Vee as launch partner to simplify how consumers get their medications through the GoodRx platform GoodRx (Nasdaq: GDRX), the leading platform for medication savings in the ...

GoodRx is a top small-cap value stock pick with strong EBITDA, new strategic leadership, and promising growth projected for FY25. Read why I'm upgrading the GDRX stock to a buy.

GoodRx has streamlined the online prescription purchase process, launching the experience with employee-owned Midwestern supermarket retailer Hy-Vee.

Read Our Latest Stock Analysis on GoodRx GoodRx Stock Down 6.1 % GDRX stock opened at $4.29 on Friday. The company has a 50 day moving average price of $4.74 and a two-hundred day moving average ...

Shares of GoodRx Holdings, Inc. (NASDAQ:GDRX – Get Free Report) have been given an average rating of “Moderate Buy” by the ten ratings firms that are covering the firm, Marketbeat Ratings reports.